NCT00660829View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

PHASE3CompletedINTERVENTIONAL
Enrollment

536

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

April 30, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Placebo

Placebo

DRUG

0.15% Azelastine Hydrochloride

0.15% Azelastine Hydrochloride 822 mcg

Trial Locations (6)

76712

Allergy and Asthma Center, Waco

78130

Central Texas Research, New Braunfels

78229

Biogenics Research Institute, San Antonio

Sylvana Research Associates, San Antonio

78731

Allergy and Asthma Associates, Austin

78759

Allergy and Asthma Center of Austin, Austin

Sponsors
All Listed Sponsors
lead

Meda Pharmaceuticals

INDUSTRY